Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × temoporfin × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 2 Tongue Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Nasopharyngeal Carcinoma 1 Carcinoma, Squamous Cell 1

Interventions

Cetuximab 13 Cisplatin 11 Paclitaxel 9 Gemcitabine 9 pembrolizumab 8 Nivolumab 6 toripalimab 5 durvalumab 5 Docetaxel 5 Carboplatin 5 Fluorouracil 4 Valproic Acid 3 Radiotherapy 3 Capecitabine 3 tremelimumab 2 spartalizumab 2 nimotuzumab 2 irinotecan sucrosofate 2 cemiplimab 2 S 1 (combination) 2 Radiation 2 NVP-BKM120 2 Methotrexate 2 Ipilimumab 2 Injections 2 Immune Checkpoint Inhibitors 2 Biopsy 2 18-O-demethylcervinomycin A2 2 vinflunine 1 tranilast 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01086488 2011-07-08

FOSCAN

Ministry of Health, Malaysia

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡